Search results
Results from the WOW.Com Content Network
Financials as of September 30, 2023. [update] [1] Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. [2]
Financials as of June 30, 2024. [update] [1] Cardinal Health, Inc. is an American multinational health care services company, and the 14th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 ...
1961 or 1962 (age 62–63) [1] South Africa. Title. Chairman, president and CEO, AmerisourceBergen. Predecessor. R. David Yost. Successor. incumbent. Steven H. Collis (born 1961) is an American businessman, the chairman, president and chief executive officer (CEO) of Cencora, previously known as AmerisourceBergen. [2][3][4][5]
AmerisourceBergen Names Peyton R. Howell as Senior Vice President, AmerisourceBergen Corporation and President, Global Sourcing and Manufacturer Relationships VALLEY FORGE, Pa.--(BUSINESS WIRE ...
(Reuters) - Walgreens Boots Alliance has sold some AmerisourceBergen Corp's shares for proceeds of about $1.85 billion, the U.S. drugstore chain said on Thursday, further cutting its ownership in ...
PharMerica. PharMerica is a Fortune 1000 company formed in January 2007 from the merger of Kindred Healthcare 's pharmacy business with a subsidiary of AmerisourceBergen. [1] The company is headquartered in Louisville, Kentucky, and operates a major customer support center in Tampa, Florida. [2]
Walgreens Boots Alliance, Inc. (WBA) is an American multinational holding company headquartered in Deerfield, Illinois, [2] which owns the retail pharmacy chains Walgreens in the US and Boots in the UK, as well as several pharmaceutical manufacturing and distribution companies. The company was formed on December 31, 2014, after Walgreens bought ...
(Reuters) -The three largest U.S. drug distributors have agreed to pay $300 million to resolve claims by health insurers and benefit plans that they helped fuel the deadly U.S. opioid epidemic ...